Log In
Print this Print this

SA4Ag (PF-06290510)

  Manage Alerts
Collapse Summary General Information
Company Pfizer Inc.
DescriptionStaphylococcus aureus vaccine composed of 4 antigens
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentPhase II
Standard IndicationStaphylococcus
Indication DetailsPrevent S. aureus infection; Prevent S. aureus infections in patients undergoing elective spinal surgery
Regulatory Designation U.S. - Fast Track (Prevent S. aureus infection)
PartnerBristol-Myers Squibb Co.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today